三星医疗收盘下跌1.31%，滚动市盈率12.91倍，总市值307.88亿元

Core Viewpoint - Samsung Medical's stock closed at 21.82 yuan, down 1.31%, with a rolling PE ratio of 12.91 times, significantly lower than the industry average of 38.92 times [1][2] Company Overview - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, and various energy solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For Q1 2025, Samsung Medical reported revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, up 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Shareholder Information - As of March 31, 2025, Samsung Medical had 16,366 shareholders, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]